Xeriant Inc reported a QQ4 2024 period with no disclosed revenue and a pronounced loss profile consistent with a development-stage aerospace tech company. Gross loss of $13,573 was driven by cost of revenue matching the minimal disclosed revenue, followed by substantial operating expenses that culminated in an operating loss of $894,111 and a net loss of $1,160,854 for the quarter. EBITDA stood at a negative $851,911, reflecting heavy R&D and G&A burn rather than stabilized operating leverage. The quarterly cash flow picture underscored liquidity constraints: operating cash flow was negative $370,451, and free cash flow was negative $370,451, while cash and equivalents at period end were $653,117. On the balance sheet, liabilities vastly exceeded assets and equity, with total liabilities of $9.33 million against assets of about $0.71 million and negative stockholders’ equity of $5.75 million, signaling meaningful solvency risk absent new financing or revenue generation. Management commentary for QQ4 2024 is not available in the provided transcript set, limiting direct quotes on strategy and execution. Overall, the quarter reinforces a high-risk, early-stage aerospace tech investment profile where the potential upside hinges on monetization of Halo/VTOL concepts, licensing deals, strategic partnerships, and access to additional equity or debt capital.”,